Matsuo Keitaro, Ito Hidemi
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute.
Nihon Rinsho. 2009 Oct;67(10):1847-51.
Epidemiologic information about specific types of leukemia in Japan is limited because limited data is available from population-based cancer registry. In this review, 1) history of International Classification of Diseases (ICD) about hematological malignancies, 2) current situation of population-based cancer registry for hematological malignancies, and 3) estimated incidence of acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) from selected population-based cancer registries (1993-2002 data from 15 registries) are presented. Estimated incidence of AML and CML in male and female in Japan are approximately half of those from SEER data in the United State. No clear change in incidence of AML/CML was observed between 1993 and 2002.
由于基于人群的癌症登记数据有限，日本特定类型白血病的流行病学信息也很有限。在本综述中，介绍了1）血液系统恶性肿瘤的国际疾病分类（ICD）历史，2）血液系统恶性肿瘤基于人群的癌症登记现状，以及3）从选定的基于人群的癌症登记处（1993 - 2002年15个登记处的数据）估计的急性髓系白血病（AML）和慢性髓系白血病（CML）发病率。日本男性和女性AML和CML的估计发病率约为美国监测、流行病学和最终结果（SEER）数据的一半。1993年至2002年期间，未观察到AML/CML发病率有明显变化。
